This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2011 Oct 29;378(9802):1529-30.

doi: 10.1016/S0140-6736(11)61421-9. Epub 2011 Sep 9.

Dalcetrapib: turning the tide for CETP inhibition?

Erik S G Stroes¹, Diederik F van Wijk

Affiliations

PMID: 21908039
DOI: 10.1016/S0140-6736(11)61421-9

Comment

Dalcetrapib: turning the tide for CETP inhibition?

Erik S G Stroes et al. Lancet. 2011.

. 2011 Oct 29;378(9802):1529-30.

doi: 10.1016/S0140-6736(11)61421-9. Epub 2011 Sep 9.

Authors

Erik S G Stroes¹, Diederik F van Wijk

Affiliation

¹ Department of Vascular Medicine, Academisch Medisch Centrum, Meibergdreef, 1105 AZ Amsterdam, Netherlands. e.s.stroes@amc.uva.nl

PMID: 21908039
DOI: 10.1016/S0140-6736(11)61421-9

No abstract available

PubMed Disclaimer

Comment on

Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial.
Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, Fuster V, Ballantyne CM, Stein EA, Tardif JC, Rudd JH, Farkouh ME, Tawakol A; dal-PLAQUE Investigators. Fayad ZA, et al. Lancet. 2011 Oct 29;378(9802):1547-59. doi: 10.1016/S0140-6736(11)61383-4. Epub 2011 Sep 9. Lancet. 2011. PMID: 21908036 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information